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Introduction {#sec001}
============

Amblyopia is a neuro-developmental disorder of the visual cortex that arises from abnormal visual experience early in life and leads to reduced visual acuity (generally in one eye) \[[@pone.0238047.ref001]\]. Amblyopia is clinically relevant because it affects between 1% and 4% of the general population \[[@pone.0238047.ref002]\]. Currently, treatment for amblyopia consists primarily of refractive error correction and penalization or occlusion of the strong eye \[[@pone.0238047.ref003]\].

Despite the fact that the diagnosis and treatment of amblyopia are defined in terms of visual acuity, a host of other visual functions are affected, both monocular and binocular \[[@pone.0238047.ref003],[@pone.0238047.ref004]\]. Amblyopia is associated with strabismus, anisometropia or their combination \[[@pone.0238047.ref005]\]. These clinical categories manifest differences in the pattern of visual loss \[[@pone.0238047.ref006],[@pone.0238047.ref007]\]. Amblyopia arises from the mismatch between the images captured by each eye; the information from one eye is favored, while input from the other eye is suppressed \[[@pone.0238047.ref008]\]. Both suppression and reduced stereo acuity are common characteristics of amblyopia \[[@pone.0238047.ref001],[@pone.0238047.ref006],[@pone.0238047.ref009]--[@pone.0238047.ref012]\]. Some (mainly strabismic) amblyopes, fail standard clinical stereotests (i.e., they cannot respond to the largest disparity). The absence of an initial measure of stereoacuity makes quantification difficult \[[@pone.0238047.ref001],[@pone.0238047.ref013]\]. Additionally, the variability of stereoacuity measurements (as much as a factor of 4) \[[@pone.0238047.ref014]\] adds uncertainty. Moreover, different tests often give different thresholds, increasing practitioner confusion \[[@pone.0238047.ref015],[@pone.0238047.ref016]\]. Successful treatment of amblyopia requires improving both the visual acuity of the amblyopic eye, and binocular vision. However, monitoring just acuity and stereoacuity might not be sufficient given the issues described above. Recent findings suggest that suppression rather than visual acuity loss limits stereoacuity in observers with amblyopia, and stereopsis improves when interocular dominance is neutralized \[[@pone.0238047.ref017]\]. Thus, the concept of suppression has been proposed as a third leg to monitor amblyopia treatment \[[@pone.0238047.ref018],[@pone.0238047.ref019]\].

Clinically, the presence and extent of the suppression scotoma is commonly assessed using the Bagolini striated lens test \[[@pone.0238047.ref019]\] or the Worth 4 dot test \[[@pone.0238047.ref020]\]. Nevertheless, recent research has pointed out the importance of measuring and quantifying the severity of suppression or interocular imbalance and several specific tests have been proposed based on determining the ratio of contrast or luminance in the two eyes that "balances" the binocular input to the primary visual cortex \[[@pone.0238047.ref021]--[@pone.0238047.ref025]\].

There have been several different laboratory approaches to measuring the binocular imbalance in patients with amblyopia \[[@pone.0238047.ref009],[@pone.0238047.ref011],[@pone.0238047.ref021]--[@pone.0238047.ref027]\]. Many of these tests require special equipment to present different images to the two eyes \[[@pone.0238047.ref011],[@pone.0238047.ref019]\]. However, variations have been developed for use with Tablets and colored filters \[[@pone.0238047.ref028],[@pone.0238047.ref029]\].

Kwon et al \[[@pone.0238047.ref027]\] proposed a test to assess binocular imbalance as a function of spatial frequency using a dichoptic letter chart. Firstly, they create a set of spatial frequency band-pass filtered Sloan letters. At each position of the dichoptic chart, the identity and interocular contrast-ratio of the letter differs while the spatial-frequency content of the letter remains the same. Participants, wearing stereo-shutter glasses, read the dichoptic letters out loud, and the balance point is calculated as the interocular contrast-ratio that gives equal probability of reporting the letters perceived in the two eyes. We found this study particularly interesting, firstly because it considers the relationship between spatial frequency and binocular imbalance degree, as found in previous studies \[[@pone.0238047.ref023]\] and secondly because it has proven its clinical feasibility \[[@pone.0238047.ref021]\].

One major drawback of tablet tests is that they may not allow full compensation for misalignment of the images in the two eyes that occur in patients with strabismus. Ding & Levi \[[@pone.0238047.ref030]\] point out that achieving binocular alignment and fusion might be the first step in the recovery of stereopsis, and for this purpose they design a dichoptic cross with binocular fusion locks, a surrounding high-contrast frame, and four luminance squares, viewed through a custom four-mirror stereoscope. One of the strabismic participants in their study achieved stereopsis through the binocular combination task alone, with no stereo training.

Image alignment can be accomplished via software in Virtual Reality (VR). Indeed, Black et al. \[[@pone.0238047.ref022]\] implemented an adjustment for vertical and horizontal misalignments and a dichoptic binocular imbalance test in a VR headset using a dichoptic cross with binocular fusion locks. Importantly, they used the results (alignment and binocular balance settings) as a starting point for a training program. VR has the potential to replace the Synoptophore (or Major Amblyoscope), as the standard instrument for the assessment and treatment of ocular motility disorders. VR has been used successfully in the treatment of mechanical strabismus and amblyopia \[[@pone.0238047.ref022],[@pone.0238047.ref031]--[@pone.0238047.ref034]\]. The recent incorporation of eye-tracking technology to VR can potentially allow the measurement of deviation angles objectively, as a preliminary study suggests \[[@pone.0238047.ref031]\].

As far as we know, the feasibility of using VR as part of routine clinical assessment of amblyopia has not been investigated yet. This motivates the present study, which we conceive to be a first step towards the design of new VR based method of assessment of binocular balance in amblyopia which can be used as a starting point for treatment.

The aim of this study was three-fold: 1) To implement a test for binocular imbalance in a Virtual Reality headset, 2) To assess the testability, reliability and outcomes of this test in a population of clinical patients and 3) To evaluate the relationship of interocular acuity difference, stereoacuity and binocular imbalance to amblyogenic risk factors (strabismus, anisometropia or their combination, referred to as 'mixed') in a large population of clinical patients.

Material and methods {#sec002}
====================

Participants {#sec003}
------------

All volunteers were recruited at the same Optometry Clinic. The data was obtained in their first visit to the clinic, after signing the Consent Agreement (minors signed the agreement together with their parents). The protocol was approved by the Regional Ethics Committee of Clinic Research (Asturias, Spain) and follows the Helsinki Declaration.

We enrolled 100 volunteers (ages 6 to 70 years old, mean 21.2 ± 16.2 years) ([S1 Table](#pone.0238047.s001){ref-type="supplementary-material"}). Of those patients, 21 volunteers had no amblyogenic factor (control group). Seventy nine have amblyopia or a history of amblyopia (24 anisometropic, 25 strabismic and 30 mixed), most of whom had received previous treatments: all of them refractive correction; 59 occlusion; 35 perceptual learning using Gabor patches to improve contrast sensitivity; 24 perceptual learning using random dot stimuli to improve stereoacuity \[[@pone.0238047.ref035]\]; and six subjects strabismus surgery.

All 55 participants with strabismus had esotropia. Exotropia is less prevalent than esotropia \[[@pone.0238047.ref036]\] and is much more likely to be intermittent exotropia \[[@pone.0238047.ref037]\]. In intermittent exotropia, binocular inhibition is low \[[@pone.0238047.ref038]\], and the deviation angle at near is generally lower than at far distances \[[@pone.0238047.ref039]\]. As a result, stereoacuity is likely to be preserved, and amblyopia is uncommon. This may explain why in our strabismus sample we find only participants with esotropia. Participants were also classified according to their response to optical correction: 16 were classified as accommodative (the deviations disappears at near and far distance with full optical correction condition) and 39 as non-accommodative (residual esotropia at near and/or far distance despite wearing full optical correction) \[[@pone.0238047.ref040]\].

Amblyopia was defined as ≥0.10 logMAR best-corrected visual acuity in the amblyopic eye and interocular difference of ≥0.2 logMAR. Anisometropia was defined as an amblyogenic factor due to a spherical equivalent interocular difference of ≥ 1.0 D \[[@pone.0238047.ref041]\]. The spherical equivalent was calculated as the sum of sphere plus half the cylinder. Strabismus was defined as an amblyogenic risk factor based on the presence of heterotropia at near or far distance, measured with the Unilateral Cover Test (UCT), with full optical correction condition and an accommodative stimulus \[[@pone.0238047.ref042]\]. Mixed amblyogenic risk factor was defined as the presence of both strabismus and anisometropia.

Exclusion criteria were congenital malformation, ocular pathology, concurrent treatment with atropine penalization, presence of diplopia in daily life conditions, prematurity ≥8 weeks, developmental delay, and coexisting ocular or systemic disease. Due to Virtual Reality headset limitations, volunteers with an interpupillary distance less than 55 mm and/or lower head circumference less than 500 mm were also excluded \[[@pone.0238047.ref043],[@pone.0238047.ref044]\].

Clinical protocol {#sec004}
-----------------

The same optometrist (author J.A.P.) evaluated all participants. Visual evaluation included: Best Corrected distance Visual Acuity (BCVA) on a logarithmic visual acuity chart (LogMAR acuity) with a polarized screen (SmarThing4vision, Spain); UCT using accommodative stimuli; refractive error by autorefractor under cycloplegia (cyclopentolate 1%) (Topcon model TRK 1P); and slitlamp and ophthalmoscopic evaluation of the anterior and posterior segment.

Binocular vision was evaluated in three different ways. Firstly, we registered patient responses (fusion, suppression or diplopia) using the Worth 4 dot test with a polarized screen, at a distance of 4 meters and for two target sizes (visual angles of 1.5° and 5.0°), following the test manufacturer's instructions (SmarThing4Vision, Spain). The Worth 4 dot test was carried out without prisms in strabismic patients to facilitate the detection of diplopia.

Secondly, binocular imbalance was measured using the VR test implemented in this paper and described below. To evaluate test-retest reliability, 20 volunteers repeated the test in a second routine visit to the clinic. Inclusion criteria for the second test were (1) no visual therapy activities between the two visits and (2) no change in visual acuity or stereoacuity. Selected volunteers represented all visual conditions.

Thirdly, we measured stereoacuity using the Randot Preschool Stereoacuity Test (RPST) conducted according to the test manufacturer's instructions (Stereo Optical, USA). Measurements were transformed from seconds of arc to log10 units for the study. A value of 3.11 in log10 units (1300 arc seconds, which Chopin et al defined as "ecological stereoblindness", was assigned to patients without measurable stereoacuity \[[@pone.0238047.ref045]\].

Binocular imbalance test in VR {#sec005}
------------------------------

Binocular imbalance was assessed using a modified version of the dichoptic eye chart proposed by Kwon et al \[[@pone.0238047.ref027]\] implemented in a Virtual Reality (VR) device (Vive by HTC Co.).

The test uses letters taken from the Sloan font alphabet and filtered to 3 cycles per letter size (cosine log filter) \[[@pone.0238047.ref046],[@pone.0238047.ref047]\]. Letters are normalized to device mean luminance and root-mean-square (RMS) contrast of 0.1. The size of the letter determines the frequency to be tested in the VR headset. Due to the resolution restrictions of the headset, the frequency selected is 0.68 cpd. Letters are located at a distance of 2.0 m in virtual space (i.e. minimal accommodation and convergence).

Importantly for strabismic patients who are unable to fuse the images, prior to the imbalance test a dichoptic nonius alignment screen is presented ([Fig 1](#pone.0238047.g001){ref-type="fig"}, [S1 Movie](#pone.0238047.s002){ref-type="supplementary-material"}). It consists of a high contrast square crossed by two lines, horizontal and vertical. Each line has four segments, two inside the square, and two outside (one on each side). Each segment is seen only by one eye. Any perceived misalignment (horizontal, vertical or cyclo) is adjusted using the software, until the patient reports the correct cyclopean perception.

![Binocular imbalance test.\
Prior to the test itself, a dichoptic nonius alignment screen is presented (bottom). The test consists of a series of trials, each one divided into three steps (from bottom to top): firstly, a fusion frame of a dichoptic nine square grid surrounded by a high contrast frame is presented to facilitate fixation. After the experimenter presses the spacebar, the computer displays two dichoptic letters, randomly selected and filtered to the target interocular contrast, for 200 msec. Finally, both letters are presented binocularly one next to the other with enhanced contrast and size. The observer's task is to indicate which letter he/she has perceived (two-alternative forced choice). The computer adjusts the imbalance ratio following a 1 up/ 1 down staircase for the next trial, until a valid threshold is obtained.](pone.0238047.g001){#pone.0238047.g001}

The test starts with a dichoptic eight squares pattern inside a high contrast frame subtending 20°, which remains visible during the test to facilitate fusion. The participant has to confirm seeing the pattern stable before starting each trial. On each trial, two randomly selected dichoptic letters are presented to the observer (one to each eye) for 200 msec., and the participant is instructed to report the letter seen (or the dominant letter in case of both are perceived simultaneously), following which both previous letters are presented side-by-side, enhanced in contrast and size, and the observer must reaffirm the one that was seen. This response is recorded by the experimenter. Stimulus duration (200msec) is set to avoid possible eye-movement effects on interocular alignment in people with strabismus.

The test follows a 1 up/1 down staircase: on each new trial, image contrast is increased for the eye that does not see the letter and decreased by the same amount for the eye that has just seen the letter. After a maximum of 16 reversals or 40 trials, the test is complete (lasting around 2 minutes). If there have been more than nine reversals, the test is considered valid. We define the mean contrast value of the last four reversals as the Imbalance Ratio (IR), i.e. fellow eye contrast divided by dominant eye contrast at which there is equal probability of reporting the optotype presented to any eye. An imbalance ratio of 1.0 means that binocular vision is perfectly balanced, whereas a ratio of 3.0 means that the amblyopic eye needs 3.0 times more contrast than the fellow eye to achieve balanced vision.

Patients can perform the test while seated, reducing the risk of VR dizziness of the fatigue due to helmet weight (approx. 500 grams). The interpupillary distance adjustment range of the headset is limited to approx. 61 to 73mm and constitutes an important limitation.

Statistical analysis {#sec006}
--------------------

We used R-Statistic (v.3.6.0) to calculate descriptive statistics. Wilcoxon signed rank test with continuity correction was used to evaluate test-retest reliability. Statistical differences between the means were calculated using the t-student test for variables that follow a normal distribution and the Mann-Whitney test is used for variables that do not conform to a normal distribution. The joint comparison of multiple groups was made using ANOVA in the case of normally distributed variables and the Kruskal-Wallis test when the variables were not normally distributed. The analysis allows us to evaluate differences between the groups (amblyogenic factor and strabismus type). Comparison of correlations between different variables was calculated using the Spearman test.

Finally, we used a logistic model to calculate the probability of belonging to different groups and to establish a 0.5 cut off point. The analysis conducts a univariate analysis to study the capacity of each classification variable in the triplet (acuity difference, imbalance factor and stereoacuity) to differentiate the groups defined by amblyogenic factor (control, anisometropia, strabismus and mixed) and refractive response (accommodative and non-accommodative).

Results {#sec007}
=======

All 100 volunteers, including 18 between the ages of 6 and 8, were able to complete the binocular imbalance test. No one reported dizziness or fatigue due to helmet weight. All participants appear to have understood the test procedure after a short explanation.

The binocular imbalance test is highly reliable. Test-retest repeatability (Wilcoxon signed rank test), gave a p-value of 0.831, showing no significant difference between first and second test. A Bland-Altman plot is included in [Fig 2](#pone.0238047.g002){ref-type="fig"}. The mean of differences is equal to -0.033, which means that first measurements are 1.033 times bigger than second results. Differences follow a normal distribution (Shapiro test, p = 0.001).

![Binocular imbalance repeatability Bland-Altman plot.\
Binocular imbalance results in first and second measurements. N = 20 volunteers.](pone.0238047.g002){#pone.0238047.g002}

To assess whether the binocular imbalance test results were consistent with standard clinical measures of suppression, we evaluated its correlation with the Worth 4 dots test. The Worth test provides patient's responses (fusion, suppression or diplopia) at two visual angles (1.5° and 5.0°). These responses were ordered according to the extent of suppression scotoma, considering diplopia as an intermediate stage between fusion and suppression, obtaining a novel scale of six categories ([Table 1](#pone.0238047.t001){ref-type="table"}). We conjecture that, if diplopia occurs with the Worth test and not in daily life conditions, it seems likely that there is suppression under normal everyday conditions, but the suppression scotoma is weak or small. For example, a subject could have diplopia at 5.0° and suppression at 1.5°. Alternatively, the patient might fuse at 5.0° degrees and suppress at 1.5°, but never fuse or exhibit diplopia at 1.5° and suppress at 5° degrees. Diplopia appears due to the highly dissociative stimuli used in Worth test. The six levels of suppression are obtained this way were highly correlated with the result of the binocular imbalance test (r = 0.538, p\<0.0001). There was also a significant correlation between Worth test and stereoacuity (r = 0.791, p\<0.0001), and between Worth test and interocular visual acuity difference (r = 0.696, p\<0.0001).

10.1371/journal.pone.0238047.t001

###### Correlation between Worth 4 dot test and triplet variables.

Mean and Standard Deviation for each variable of the triplet (interocular visual acuity difference, stereoacuity and imbalance factor) for each category considered of Worth test. Worth test answers have been ordered according to the extent of suppression scotoma, considering diplopia as an intermediate stage between fusion and suppression. Number of occurrences in the sample, N, is also included. Correlations and p-values between Worth test categories and each variable of the triplet are included in the last row.

![](pone.0238047.t001){#pone.0238047.t001g}

  Worth test categories   N                     Acuity difference     Imbalance Factor      Stereoacuity                 
  ----------------------- --------------------- --------------------- --------------------- -------------- ------ ------ ------
  0 (1.5 F + 5.0 F)       57                    0.04                  0.07                  1.54           0.75   1.91   0.40
  1 (1.5 D + 5.0 F)       1                     0.00                                        1.63                  2.90   
  2 (1.5 D + 5.0 D)       10                    0.03                  0.04                  2.65           1.87   3.11   0.00
  3 (1.5 S + 5.0 F)       10                    0.21                  0.13                  1.88           0.88   2.75   0.46
  4 (1.5 S + 5.0 D)       15                    0.37                  0.24                  6.29           4.40   3.10   0.05
  5 (1.5 S + 5.0 S)       7                     0.72                  0.25                  7.64           5.02   3.04   0.19
  Correlation (p-value)   0.696 (p \< 0.0001)   0.538 (p \< 0.0001)   0.791 (p \< 0.0001)                                

F: fusion; D: diplopia; S: suppression; 1.5 degrees and 5.0 degrees of visual angle.

Moreover, as summarized in [Table 2](#pone.0238047.t002){ref-type="table"}, the binocular imbalance test correlated with LogMAR interocular visual acuity difference (r = 0.575, p\<0.0001) and stereoacuity (r = 0.675, p\<0.0001). LogMAR acuity difference and stereoacuity were also correlated (r = 0.601, p\<0.0001). Those correlations were positive when analyzing the whole dataset, and also occur in some cases when considering the clinic subgroups of patients, by amblyogenic risk factor and by refractive response.

10.1371/journal.pone.0238047.t002

###### Correlation between triplet variables at each clinic group.

Correlation values (Spearman test) between pairs of the continuous variables of the study (acuity difference, stereoacuity and imbalance factor), considering all patients and each group individually, classified according to amblyogenic factor (anisometropia, strabismus and mixed) and considering refractive response (accommodative and non-accommodative).

![](pone.0238047.t002){#pone.0238047.t002g}

  Comparison                              All patients                                             Anisometropia                                            Strabismus                                              Mixed                                                    Accommodative      Non-accomm.
  --------------------------------------- -------------------------------------------------------- -------------------------------------------------------- ------------------------------------------------------- -------------------------------------------------------- ------------------ --------------------------------------------------------
  Acuity difference vs Imbalance factor   0.575 (p \< 0.01)[\*](#t002fn001){ref-type="table-fn"}   0.390 (p = 0.06)                                         0.532 (p = 0.01)[\*](#t002fn001){ref-type="table-fn"}   0.666 (p \< 0.01)[\*](#t002fn001){ref-type="table-fn"}   0.361 (p = 0.17)   0.664 (p \< 0.01)[\*](#t002fn001){ref-type="table-fn"}
  Acuity difference vs Stereoacuity       0.601 (p \< 0.01)[\*](#t002fn001){ref-type="table-fn"}   0.678 (p \< 0.01)[\*](#t002fn001){ref-type="table-fn"}   0.428 (p = 0.03)[\*](#t002fn001){ref-type="table-fn"}   0.412 (p = 0.02)[\*](#t002fn001){ref-type="table-fn"}    0.168 (p = 0.53)   0.251 (p = 0.12)
  Imbalance factor vs Stereoacuity        0.675 (p \< 0.01)[\*](#t002fn001){ref-type="table-fn"}   0.421 (p = 0.04)[\*](#t002fn001){ref-type="table-fn"}    0.395 (p = 0.05)                                        0.560 (p \< 0.01)[\*](#t002fn001){ref-type="table-fn"}   0.154 (p = 0.57)   0.332 (p = 0.04)[\*](#t002fn001){ref-type="table-fn"}

\* Significant correlation because p-value is less than 0.05.

We assessed the sensitivity of the binocular imbalance test for detecting inter-observer differences based on amblyogenic risk factors: control, anisometropia, strabismus and mixed. Additionally, we classified the volunteers included in the strabismus and mixed groups according to their refractive response: accommodative and non-accommodative. Consistent with previous studies \[[@pone.0238047.ref019],[@pone.0238047.ref021]\], the mixed group clearly shows the worst visual acuity difference, stereoacuity and imbalance factor ([Table 3](#pone.0238047.t003){ref-type="table"}). Among patients in the strabismus and mixed groups, the non-accommodative group performing poorly on all 3 measures. This can be seen clearly in [Fig 3](#pone.0238047.g003){ref-type="fig"}, which shows the distribution of the triplet variables using box plots for each group. Importantly, only 1 accommodative patient out of 16 is stereoblind, whereas 33 out of 39 non-accommodative patients are stereoblind.

![Triplet variables box plots.\
Graphical display of the continuous variables (LogMAR acuity difference, log10 stereoacuity and imbalance factor) using boxplots for each classification groups: amblyogenic factor (control, anisometropic, strabismus and mixed) and deviation nature (accommodative and non-accommodative). The box plot shows the mean and distribution in quartiles of the data. Circles represents each single participant.](pone.0238047.g003){#pone.0238047.g003}

10.1371/journal.pone.0238047.t003

###### Mean and Standard Deviation for triplet variables.

Interocular visual acuity difference, stereoacuity and imbalance factor mean and standard deviation for each group, classified according to amblyogenic factor (control, refractive, strabismus and mixed) and considering refractive response (accommodative and non-accommodative).

![](pone.0238047.t003){#pone.0238047.t003g}

                               Acuity difference   Imbalance factor   Stereoacuity                   
  ----------------------- ---- ------------------- ------------------ -------------- ------- ------- -------
  *Amblyogenic factor*                                                                               
  Control                 21   0.000               0.000              1.246          0.152   1.648   0.123
  Anisometropia           24   0.129               0.165              1.506          0.660   2.085   0.501
  Mixed                   25   0.246               0.270              4.395          3.925   2.724   0.511
  Strabismic              30   0.191               0.288              3.540          3.542   2.865   0.474
  *Refractive response*                                                                              
  Accommodative           16   0.073               0.072              1.861          1.066   2.092   0.356
  Non-accommodative       39   0.282               0.307              4.887          4.094   3.074   0.105

To delve more deeply into the differences between groups, we carried out a means paired comparison ([Table 4](#pone.0238047.t004){ref-type="table"}). Both group classifications, amblyogenic factor and refractive response, were analyzed. Whereas the strabismus and mixed groups show no significant mean differences in any of the variables, accommodative and non-accommodative groups show significant differences in all three variables. Binocular imbalance is the only variable that shows significant differences between the accommodative and anisometropia groups (p = 0.042). On the other hand, imbalance is the only variable of the triplet that fails to differentiate control vs anisometropia groups. Finally, interocular acuity difference is the only variable of the triplet that fails to differentiate the anisometropia group from the mixed (p = 0.093) and non-accommodative groups (p = 0.063).

10.1371/journal.pone.0238047.t004

###### Means pair comparison between group pairs for each triplet variable.

P-value and significance (p-value\< 0.05) for each triplet variable (visual acuity difference, stereoacuity and imbalance factor) per each group classification pair. Both group classifications are considered, amblyogenic factor (control, refractive, strabismus and mixed) and refractive response (accommodative and non-accommodative).

![](pone.0238047.t004){#pone.0238047.t004g}

                                   Acuity diffrence   Stereoacuity                            Imbalance factor                                                     
  -------------------------------- ------------------ --------------------------------------- ------------------ --------------------------------------- --------- ---------------------------------------
  Control vs Anisometropia         \< 0.01            [\*](#t004fn001){ref-type="table-fn"}   \< 0.01            [\*](#t004fn001){ref-type="table-fn"}   0.33      
  Control vs Strabismic            \< 0.01            [\*](#t004fn001){ref-type="table-fn"}   \< 0.01            [\*](#t004fn001){ref-type="table-fn"}   \< 0.01   [\*](#t004fn001){ref-type="table-fn"}
  Control vs Mixed                 \< 0.01            [\*](#t004fn001){ref-type="table-fn"}   \< 0.01            [\*](#t004fn001){ref-type="table-fn"}   \< 0.01   [\*](#t004fn001){ref-type="table-fn"}
  Mixed vs Anisometropia           0.09                                                       \< 0.01            [\*](#t004fn001){ref-type="table-fn"}   \< 0.01   [\*](#t004fn001){ref-type="table-fn"}
  Mixed vs Strabismic              0.15                                                       0.37                                                       0.26      
  Anisometropia vs Strabismic      0.81                                                       \< 0.01            [\*](#t004fn001){ref-type="table-fn"}   0.001     [\*](#t004fn001){ref-type="table-fn"}
  Accommodative vs Control         \< 0.01            [\*](#t004fn001){ref-type="table-fn"}   \< 0.01            [\*](#t004fn001){ref-type="table-fn"}   \< 0.01   [\*](#t004fn001){ref-type="table-fn"}
  Control vs Non-accommodative     \< 0.01            [\*](#t004fn001){ref-type="table-fn"}   \< 0.01            [\*](#t004fn001){ref-type="table-fn"}   \< 0.01   [\*](#t004fn001){ref-type="table-fn"}
  Accommodative vs Non-accomm      0.03               [\*](#t004fn001){ref-type="table-fn"}   \< 0.01            [\*](#t004fn001){ref-type="table-fn"}   \< 0.01   [\*](#t004fn001){ref-type="table-fn"}
  Accommodative vs Anisometropia   0.54                                                       0.45                                                       0.04      [\*](#t004fn001){ref-type="table-fn"}
  Non-accomm vs Anisometropia      0.06                                                       \< 0.01            [\*](#t004fn001){ref-type="table-fn"}   \< 0.01   [\*](#t004fn001){ref-type="table-fn"}

\* Significant correlation because p-value is less than 0.05.

The univariate logistic models allow a comparison of the significance of each continuous variable to differentiate any group considered of patients from controls ([Table 5](#pone.0238047.t005){ref-type="table"}). The stereoacuity variable shows the ROC Area Under the Curve best results, above 0.9 in most cases, when compared to the rest of the univariate logistic models i.e. it provides the best differentiation of any group from controls (except anisometropia, with the lower ROC AUC value, 0.82, still high). The imbalance factor also provides strong differentiation, above 0.8 in most cases, better or similar to interocular acuity difference except for anisometropia group (ROC AUC value = 0.59).

10.1371/journal.pone.0238047.t005

###### Univariate logistic classification models.

Results obtained by three different models, based on acuity difference, stereoacuity and imbalance factor, when differentiating control group from others: amblyogenic factor (anisometropia, strabismus or mixed) and refractive response (accommodative or non-accommodative).

![](pone.0238047.t005){#pone.0238047.t005g}

                                     ROC AUC   Sensitivity   Specificity   PPV    NPV
  ---------------------------------- --------- ------------- ------------- ------ ------
  **Control vs Anisometropia**                                                    
  Acuity difference                  0.83      1.00          0.67          0.72   1.00
  Stereoacuity                       0.82      0.86          0.75          0.75   0.86
  Imbalance factor                   0.59      0.52          0.54          0.50   0.57
  **Control vs Strabismic**                                                       
  Acuity difference                  0.84      1.00          0.68          0.72   1.00
  Stereoacuity                       0.97      0.90          0.92          0.90   0.92
  Imbalance factor                   0.83      0.95          0.72          0.74   0.95
  **Control vs Mixed**                                                            
  Acuity difference                  0.88      1.00          0.77          0.75   1.00
  Stereoacuity                       0.98      0.90          0.97          0.95   0.94
  Imbalance factor                   0.93      0.86          0.87          0.82   0.90
  **Control vs Accommodative**                                                    
  Acuity difference                  0.81      1.00          0.63          0.78   1.00
  Stereoacuity                       0.92      0.90          0.81          0.86   0.87
  Imbalance factor                   0.87      0.86          0.75          0.82   0.80
  **Control vs Non-accommodative**                                                
  Acuity difference                  0.88      1.00          0.77          0.70   1.00
  Stereoacuity                       1.00      1.00          1.00          1.00   1.00
  Imbalance factor                   0.89      0.95          0.85          0.77   0.97

ROC.AUC: Area under the curve; PPV: Positive Predictive Value (PPV); NPV: Negative Predictive Value.

Discussion {#sec008}
==========

The first aim of this study was to implement a test of binocular balance in Virtual Reality (VR) that could be used in a clinical setting. We conducted the test on 100 volunteers (including juveniles) with different visual conditions. The test procedure was easy to understand by patients, and test duration, around 2 minutes, was short enough to maintain attention even with younger volunteers. There were no reports of dizziness or fatigue due to helmet weight. Nevertheless, there are several limitations to consider. The first limitation is the limited range of interpupillary distance adjustment (approx. 61 to 73mm). Manufacturers should solve this limitation in future releases, as it affects an important percentage of the potential customers of VR products \[[@pone.0238047.ref043],[@pone.0238047.ref048],[@pone.0238047.ref049]\], particularly children younger than 7 years old. The wrong IPD adjustment can lead to incorrect judgment of depth and could potentially induce motion related sickness or disorientation.

Virtual Reality (VR) may become a promising tool for amblyopia treatment. This test could provide relevant information for setting the interocular contrast for perceptual learning or videogame play based in VR technology. However, due to a second limitation, the low resolution of VR headsets, binocular imbalance could only be tested at 0.68 cpd. Binocular imbalance due to amblyopia is more evident at high frequencies \[[@pone.0238047.ref024]\]. Thus, the discriminative power of the binocular imbalance test may be better if the test is conducted at higher frequencies, something that technology\'s natural evolution will provide us in the near future.

Although the purpose of the test is to measure binocular imbalance, the stimuli used would vary in size if the frequency tested were different. All tests based on dichoptic optotypes share this third limitation: the binocular imbalance is measured at a certain fixed frequency and size (visual angle) relationship. In our implementation, the optotype subtends a visual angle of 4.4°. As the Worth 4 dot test results show, suppression is more evident at smaller visual angles. Thus, it would be desirable to perform the test at a smaller visual angle, i.e., at a higher frequency.

The overlapping optotypes approach used in the binocular imbalance test proposed has high test-retest reliability (intra-observer consistency) in previous implementations \[[@pone.0238047.ref050]\]. Here we confirmed the high test-retest reliability in our VR implementation.

Test validity was assessed using three complementary strategies. Firstly, we found a significant correlation between the binocular imbalance test and the Worth test results ([Table 1](#pone.0238047.t001){ref-type="table"}). Although the Worth test measures the extent of the suppression scotoma rather than its intensity, it is reasonable to expect a correlation between the two. Our novel Worth test score assumes diplopia as an intermediate stage between fusion and suppression. Considering diplopia and performing the test at different sizes, we have a broader scale than the one proposed by Webber et al. \[[@pone.0238047.ref018]\]. They proposed a composite binocular function score derived from clinical stereoacuity measures and the Worth 4 Dot response at 33 cm; and found a high correlation with the inter-ocular contrast balance test proposed by Kwon et al. \[[@pone.0238047.ref027]\]. We have replicated that correlation, but between the Worth test alone (without combining it with stereoacuity data) and the binocular imbalance test. This avoids any bias in the result due to the already known correlation between stereoacuity and binocular imbalance. However, it should be noted that the binocular imbalance measure may not simply reflect suppression, since it does not separate out reduced monocular sensitivity from the effects of binocular suppression.

It also should be noted that it would have been desirable to perform the binocular imbalance test at a smaller visual angle and higher frequency. Our proposed Worth 4 Dot scale fails when we compare the binocular imbalance results between categories 2 (mean 2.65 ±1.87) and 3 (mean 1.88 ±0.88). A subject with diplopia at 1.5° and 5.0° (i.e. category 2) is expected to have a large suppression scotoma in extent, but with a weak intensity, whereas a subject who fuses at 5.0° but suppresses at 1.5° (i.e. category 3) would have a smaller scotoma in extent but deeper in intensity. The second subject is more likely to exhibit higher binocular imbalance than the first. Nevertheless, this hypothesis was not confirmed, we believe that due to the size of the stimuli used in the VR test (4.4°).

In a second analysis of the VR test validity, we found significant correlations between the binocular imbalance results and both stereoacuity and LogMAR interocular acuity differences when considering the whole dataset ([Table 2](#pone.0238047.t002){ref-type="table"}). Inter-observer discriminatory power provides a third line of evidence for the validity of the binocular imbalance test (discussed below).

The data collected for this study are representative of the problems faced in clinics where amblyopic patients are seen. Most patients have received prior treatment for amblyopia, focused on recovering visual acuity, using occlusion (59 volunteers; 11 out of 24 subjects in the anisometric group; 25 out of 30 in the mixed group; and 23 out of 25 in the strabismus group). Mean interocular visual acuity differences are relatively low thanks to those previous treatments, but the visual problem persists as stereoacuity and the imbalance factor values show ([Table 3](#pone.0238047.t003){ref-type="table"}, [Fig 3](#pone.0238047.g003){ref-type="fig"}). According to the standard acuity definition of amblyopia, only 27 participants would be considered to be amblyopic. However, when the other variables of the triplet are considered, the presence of a visual loss is clearly manifested.

The three variables of the triplet have different behaviors depending on group classification. The 3 variables are correlated for the whole dataset and, in several cases, when considering the clinic subgroups of patients ([Table 2](#pone.0238047.t002){ref-type="table"}). Nevertheless, their mean values differ significantly, depending on group classification ([Table 3](#pone.0238047.t003){ref-type="table"}). These results confirm and extend previous attempts to compare clinical subgroups using binocular imbalance, acuity differences and stereoacuity \[[@pone.0238047.ref019]\].

Anisometropic patients show clearly worse stereoacuity and larger acuity differences than the control group ([Table 3](#pone.0238047.t003){ref-type="table"}). As previously shown, most purely anisometropic patients retain some stereopsis \[[@pone.0238047.ref008]\] (only 2 out of 24 participants had no measurable stereoacuity). Anisometropic amblyopes have stereopsis at low, but not high, spatial frequencies, suggesting that while their stereoacuity is not as acute as normal, it is nevertheless functional \[[@pone.0238047.ref012]\]. Anisometropic patients show low imbalance factors (mean value 1.5, meaning that the amblyopic eye needs 1.5 times more contrast than the fellow eye to achieve balanced vision), only slightly higher than the control group ([Table 3](#pone.0238047.t003){ref-type="table"}). The imbalance factor fails to differentiate anisometropic patients from controls (means pair comparison, [Table 4](#pone.0238047.t004){ref-type="table"}). Accordingly, our logistic model shows poor results when imbalance factor is used to detect anisometropic patients (ROC Area under the curve 0.59), compared with stereoacuity or acuity difference models ([Table 5](#pone.0238047.t005){ref-type="table"}). The regional extent and depth of suppression in patients with anisometropia did not differ from controls in previous studies when they were assessed at low spatial frequencies, as in the current study (0.68 cpd) \[[@pone.0238047.ref023],[@pone.0238047.ref051]\]. However, in amblyopic patients, binocular imbalance increases with spatial frequency and the factor could be as much as 2--8 at 2.72 cpd \[[@pone.0238047.ref023],[@pone.0238047.ref024]\]. In the future, improved resolution in VR headsets may allow testing at higher spatial frequencies, and this might help to differentiate anisometropic patients.

On the other hand, the imbalance factor provides important information for characterizing strabismic and mixed groups \[[@pone.0238047.ref025]\] (mean imbalance factor amounts to 4.4 for mixed and 3.5 for strabismic, whereas it is only 1.5 for anisometropia, [Table 3](#pone.0238047.t003){ref-type="table"}). Suppression in strabismus may be different from suppression in anisometropia, active in the former, to avoid diplopia, and more passive in the latter, because of visual acuity loss in the amblyopic eye \[[@pone.0238047.ref001]\]. Stereopsis is also more impacted in strabismic than in anisometropic amblyopia \[[@pone.0238047.ref001],[@pone.0238047.ref008]\], as our data corroborates: mean value of log10 stereoacuity in anisometropia is 2.1, whereas mixed and strabismic groups show 2.7 and 2.9 respectively ([Table 3](#pone.0238047.t003){ref-type="table"}).

The logistic model using stereoacuity or imbalance factor as predictors shows strong differentiation among subgroups ([Table 5](#pone.0238047.t005){ref-type="table"}). However, a high proportion of strabismic (17 out of 25) and mixed (17 out of 30) participants fall into the category of stereoblind. The imbalance factor variable would allow tracking a patient's evolution on the path to recovering stereovision in much more subtle detail, especially when using a dichoptic training approach \[[@pone.0238047.ref001],[@pone.0238047.ref014],[@pone.0238047.ref052]\]. Thus, stereoacuity is a good red flag for detecting the presence of an amblyogenic factor, but it is not the best variable for quantifying the severity of the problem. On the other hand, the imbalance factor is a good detection variable according to the logistic model, and solves the clinic problem of quantifying the severity of the problem.

Interestingly, whereas mean differences are not significant for any variable of the triplet between strabismic and mixed groups ([Table 4](#pone.0238047.t004){ref-type="table"}), all show significant differences between accommodative and non-accommodative subgroups. A patient whose deviation can be resolved at near and far just using the appropriate refraction is likely to show a much better baseline triplet: low dominance and gross stereoacuity (only 1 out of 16 accommodative patients is stereoblind). This seems reasonable, as both images are reasonably well correlated, and should fall within Panum's area \[[@pone.0238047.ref053]\]. On the other hand, if the refractive correction does not completely resolve the deviation, there is a high chance of being stereoblind (33 out of 39 in our sample are stereoblind) and having a high imbalance factor. Accommodative patients do not manifest strabismus and therefore are receiving spatially concordant binocular visual inputs for most of their waking hours. Consequently, they have a better prognosis than non-accommodative strabismus patients \[[@pone.0238047.ref054]\]. Although different in etiology, both anisometropia and accommodative groups show a similar baseline triplet. In fact, accommodative and anisometropia groups show only mild mean differences in binocular imbalance ([Table 4](#pone.0238047.t004){ref-type="table"}).

Conclusions {#sec009}
===========

The binocular imbalance test, using a Virtual Reality device, is easy for patients to understand, fast, repeatable and valid. VR is a promising technique in amblyopia treatment. Adjusting contrast to rebalance binocular vision within a VR headset opens the possibility of new treatments based on this technology.

Our results stress the importance of monitoring amblyopia in clinical practice not only taking into account visual acuity, but also stereoacuity and interocular imbalance. Patching and visual therapy outcomes should be tracked using this triplet. Amblyopia is not only a monocular disorder, but also a binocular problem. Stereoacuity on its own is not sufficient to quantify the effects of treatment, because of the high percentage of patients with no measurable initial stereoacuity. Measuring binocular imbalance may help to fill that gap.

Each amblyogenic risk factor (anisometropia, strabismus or mixed) has a different representation in the triplet space. Moreover, the results emphasize the importance of determining the nature of the deviation: accommodative strabismus has a better prognosis than non-accommodative strabismus.

Supporting information {#sec010}
======================

###### Raw data.

(CSV)

###### 

Click here for additional data file.

###### Binocular imbalance test in VR.

(MP4)

###### 

Click here for additional data file.
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Line 110: "All 55 participants with strabismus had esotorpia": This needs thorough explanation. In the age group described it is expected to have a good number of exotropia cases. Some may argue that you may even expect to see more exotropia than esotropia. The only was the authors ended up with 55 amblyopes with strabismus and the 55 had esotropia is that they were selecting esotropia and excluding exotropia and we don't see that in their exclusion criteria. And if that was the case, why only choose esotropes? Moreover, the authors did not exclude patients with previous strabismus surgery. In the raw data table the only surgery mentioned is cataract surgery. Again, it is very unlikely in such group with strabismus in this age group to have no surgical history unless you are excluding surgical cases.

Lines 115 -- 116: "Anisometropia was defined \... \>=1 D". Where did the authors get this definition? Reference 39 cited at the end of this sentence is an article describing the effect of amblyopia treatment on stereoacuity and although they used 1D of interocular difference to define anisometropia, yet, they did not investigate if this number was significant. A one diopter difference in a bilateral myope of 8 and 9 D is not like a 1 D difference in a unilateral hypertmetropa of 1D. Lumping up all the anisometropes together under 1 D may not be clinically relevant.

Lines 125 -126: The UCT test for strabismus is repeated here. It was described few lines above.

Line 217: Did the authors use prisms while doing the W4D test on strabismic patients? Authors corrected for misalignment in the VR test. In order for the W4D and the VR test to be comparable, both have to correct (or not correct) for misalignment.

Line 233: This categorization of the W4D result is interesting. If it is has been described before please add the reference. If it is devised by the authors please explain what made you come up with this grading. For example: why would someone with diplopia at both angles be classified as better than someone who can fuse at 5 degs but suppress at 1.5 degs. If this diplopia is manifest then definitely his binocularity and stereo should be graded less than a patient who can fuse for near.
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EDITOR

Please ensure that your manuscript meets PLOS ONE\'s style requirements, including those for file naming.

We have reviewed the style requirements, particularly regarding reference citations

Please include an updated Competing Interests statement in your cover letter

We have added the sentence \"This does not alter our adherence to PLOS ONE policies on sharing data and materials" as requested in the cover letter.

The authors should provide more details with illustrated figures to better demonstrate how they used virtual reality interface.

We have included a video in the complementary materials section to explain how virtual reality interface works. We have also modified figure 1 to explain better the proposed test.

Reviewer \#1

The topic is interesting and a new revolution in the management of amblyopia. It is, however, tough and understood with a great effort, which the reader might not always with to spend. I suggest adding more figures of the materials used and steps done to further clarify the topic to the reader. I also suggest more detailed explanation of the principle of the test and virtual reality in a simplified way. In general, it is well written and high ranking but difficult for an average reader to understand readily. Try to simplify it and go step by step wit the reader, while using the aid of more figures.

We have included a video in the complementary materials section to explain how virtual reality interface works. We have also modified figure 1 to better explain the proposed test. We have added in the Introduction section a description of the test proposed by Kwon et al in 2015 and we have also explained why we selected this test specifically as benchmark for the VR test.

 

Reviewer \#2: Authors did a good work with the VR device. This trend may be the future of amblyopia therapy. Here are few comments.

Line 26: "The triplet": I assume the authors mean by the triplet the three factors together as the word in mentioned again in line 31. It is not readily clear to readers what the triplet in line 26 means. Please clarify.

We have changed line 26 to make it easier to understand.

Lines 55-57: "The absence of stereoacuity.... Treatment": This might be a bit of an overstatement and not fully supported by the cited papers. There is uncertainty in measuring stereoacuity in amblyopes, and there is uncertainty in following improvement in stereoacuity. However, this does not create major uncertainty in tracking the improvement in amblyopia in general.

The idea we want to stress is that if we wish to quantify the improvement in binocularity, the absence of an initial measure of stereoacuity and the poor test-retest reliability of many standard clinical tests, makes quantification difficult. We have changed the previous sentence in the paper to explain this idea more clearly, and we have added a reference to a recent paper by Webber et al. 2020 that deeps in the importance of dominance in amblyopia.

Lines 74 -- 75: "Black et al.. headset": The references cited here are confusing. Reference 21 describes aligning both image by moving a line on the screen before stating the test. This particular study did not test or verify the technique used to compensate for misalignment. Authors may consider referring to another study that focus on this. Reference 30 at cited at the end of the sentence is a study about binocular influence on global motion processing and does not describe any use of VR headset.

Reference \[30\] was included in this sentence because it explains the fundamentals of the dichoptic binocular imbalance test used in reference \[21\]. Nevertheless, it might be confusing as the reviewer points out, so it has been removed. In order to explain better the importance of compensating any misalignment we have included a new reference focused on this topic and modified the text accordingly \[A\].

\[A\] Recovery of stereopsis through perceptual learning in human adults with abnormal binocular vision. Jian Ding and Dennis M. Levi. PNAS \| September 13, 2011 \| vol. 108 \| no. 37 \| E733--E741

Line 78: "VR combined": Please explain what you mean by VR combined. The term does not appear to be common in literature or it may be a truncated sentence.

We apologize, the term "combined" is now deleted, it was an erratum.

Lines 86: Please mention the reference (Kwon et al) in the regular fashion not in line with the text.

We have modified the style for this reference

Lines 86: The first aim of the study is to "implement a test .. in a VR headset". It is understandable to readers that this test was designed and published by Kwon et al in 2014 and the authors are using this test in their VR devise. I would have expected the authors to dedicate few lines of their introduction describing this test and why did they select this particular test to use in their device. I assumed that they meant reference number 26. This should be made easier for readers to find. This is the highlight of the introduction and I believe authors could have spent less time going over all the progress made by VR devices and focus more on describing the tests that that will use and aim to implement in a mainstream VR device.

We want to stress here that, due to our mistake, the date of the reference was wrong, as we meant reference number \[27\] (according to the first manuscript version) and not \[26\]. We have added in the Introduction section a description of the test proposed by Kwon et al in 2015 and we have also explained why we selected this test specifically as benchmark for the VR test.

Line 88 and 90: "Large population of clinical patients": I would not consider 100 volunteers (of which 21 are controls) recruited in one optometry clinic a large population of clinical patients.

We have leave out the term "large" from this sentence and the title of the paper.

Line 98: Inclusion criteria should come before the exclusion.

Exclusion criteria has been moved to the end of Participant's section.

Line 103: Authors do not state who were they recruiting as cases (not control). Were they recruiting any patient with amblyopia? Or any patient with amblyogenic factor even if there was no amblyopia present? Or any patient with a history of amblyopia as taken from previous files? Where is the cases selection criteria?

Inclusion criteria refers to patients with amblyopia or with a history of amblyopia that had been treated successfully. We have clarified this point in the Participant's section and in the Abstract.

Line 110: "All 55 participants with strabismus had esotropia": This needs thorough explanation. In the age group described it is expected to have a good number of exotropia cases. Some may argue that you may even expect to see more exotropia than esotropia. The only was the authors ended up with 55 amblyopes with strabismus and the 55 had esotropia is that they were selecting esotropia and excluding exotropia and we don't see that in their exclusion criteria. And if that was the case, why only choose esotropes?

Esotropia (ET) is the most common form of strabismus, accounting between half to two thirds of all misaligned eyes \[A\]. Exotropia (XT) has low prevalence: when present, it takes the form of intermittent exotropia in most of the cases, while constant exotropia is much less common \[B\]. Binocular inhibition is low in intermittent XT \[C\]; and the deviation grade in near is lower than in far distances \[D\]. In fact, fine stereoacuity at near distance is a common clinical finding in intermittent XT. According to our clinical experience, amblyopia is uncommon in intermittent XT.

This explains why our strabismus sample only had ET, taking into account that we have included only patients with amblyopia or with a history of amblyopia.

We have clarified this point in the Participant's section.

\[A\] Pai A, Mitchell P. Prevalence of amblyopia and strabismus. Ophthalmology. 2010;117(10):2043--2044.

\[B\] Govindan M, Mohney BG, Diehl NN, Burke JP. Incidence and types of childhood exotropia: a population-based study. Ophthalmology. 2005;112(1):104-108.

\[C\] Ahn SJ, Yang HK, Hwang JM. Binocular visual acuity in intermittent exotropia: role of accommodative convergence. Am J Ophthalmol. 2012;154(6):981.

\[D\] Mohney BG, Holmes JM. An office-based scale for assessing control in intermittent exotropia. Strabismus. 2006;14(3):147-150. doi:10.1080/09273970600894716

Line 110: Moreover, the authors did not exclude patients with previous strabismus surgery. In the raw data table the only surgery mentioned is cataract surgery. Again, it is very unlikely in such group with strabismus in this age group to have no surgical history unless you are excluding surgical cases.

Reviewer is right. The clinic does not practice strabismus surgery, but data was available in the anamnesis form. Six patients had previous strabismus surgery. This information is now included in the complementary material and cited in the text.

Lines 115 -- 116: "Anisometropia was defined \... \>=1 D". Where did the authors get this definition? Reference 39 cited at the end of this sentence is an article describing the effect of amblyopia treatment on stereoacuity and although they used 1D of interocular difference to define anisometropia, yet, they did not investigate if this number was significant. A one diopter difference in a bilateral myope of 8 and 9 D is not like a 1 D difference in a unilateral hypertmetropa of 1D. Lumping up all the anisometropes together under 1 D may not be clinically relevant.

While the reviewer is correct, every published RCT (including the PEDIG studies) had used a fixed dioptric definition, generally \>=1. We have adopted this definition so that our results can be readily compared with previous work.

Some references with the same criteria are:

\[A\] Wong TY, Foster PJ, Hee J, et al. Prevalence and risk factors for refractive errors in adult Chinese in Singapore. Invest Ophthalmol Vis Sci. 2000;41(9):2486-2494.

\[B\] Dobson V, Harvey EM, Miller JM, Clifford-Donaldson CE. Anisometropia prevalence in a highly astigmatic school-aged population. Optom Vis Sci. 2008;85(7):512-519. doi:10.1097/OPX.0b013e31817c930b

\[C\] Deng L, Gwiazda JE. Anisometropia in children from infancy to 15 years. Invest Ophthalmol Vis Sci. 2012;53(7):3782-3787. Published 2012 Jun 20. doi:10.1167/iovs.11-8727

\[D\] Afsari S, Rose KA, Gole GA, et al. Prevalence of anisometropia and its association with refractive error and amblyopia in preschool children. Br J Ophthalmol. 2013;97(9):1095-1099. doi:10.1136/bjophthalmol-2012-302637

\[E\] Lee C-W, Fang S-Y, Tsai D-C, Huang N, Hsu C-C, Chen S-Y, et al. (2017) Prevalence and association of refractive anisometropia with near work habits among young schoolchildren: The evidence from a population-based study. PLoS ONE 12(3): e0173519. <https://doi.org/10.1371/journal.pone.0173519>

Lines 125 -126: The UCT test for strabismus is repeated here. It was described few lines above.

We have shortened the sentence to avoid duplication.

Line 217: Did the authors use prisms while doing the W4D test on strabismic patients? Authors corrected for misalignment in the VR test. In order for the W4D and the VR test to be comparable, both have to correct (or not correct) for misalignment.

We do not state that W4D test and VR test measure the same problem. We just analyze the agreement between W4D test and the three variables used in the study (acuity, stereoacuity and binocular imbalance) proposing an original W4D scale. We want to analyze the coherence and differences between these different measurements. We find relevant W4D because it is widely used in daily clinic practice.

W4D test was carried out without prisms in strabismic patients because we want to assess not only if there is suppression or if the patient can fuse, but also if there is diplopia under dissociated stimuli (the red/green dots used in W4D test are highly dissociative).

We should have stated in the exclusion criteria, the presence of diplopia in daily life conditions (now we have included this). If diplopia shows up in W4D test and not in daily life conditions, it means that there is suppression in daily life conditions, but the suppression scotoma is weak or small in extent. This idea is at the root of the scale propose for W4D test.

The VR test uses a virtual prism to avoid diplopia because we want to measure the degree of binocular imbalance. Surprisingly, even if we correct the deviation angle and we consider amblyopia treatment successful, we found an anomalous binocular imbalance.

As a result of this discussion we have modified the exclusion criteria section and made a deeper explanation of how W4D test was carried out.

Line 233: This categorization of the W4D result is interesting. If it has been described before please add the reference. If it is devised by the authors please explain what made you come up with this grading. For example: why would someone with diplopia at both angles be classified as better than someone who can fuse at 5 degs but suppress at 1.5 degs. If this diplopia is manifest then definitely his binocularity and stereo should be graded less than a patient who can fuse for near.

As explained before, if diplopia shows up in W4D test and not in daily life conditions, it means that there is suppression, but the suppression scotoma is weak. A subject could have diplopia at 5 degrees and suppression at 1.5 degrees. Or the patient could fuse at 5 degrees and suppress at 1.5 degrees. But will never fuse or exhibit diplopia at 1.5 and suppress at 5 degrees. Diplopia appears only due to the highly dissociative stimuli used in W4D test.

This idea is at the root of the scale propose for W4D test. Considering diplopia and performing the test at different angles, we have a broader scale than the one proposed by Webber et al.

A subject with diplopia at both angles has a large suppression scotoma in extent, but with a weak intensity. A subject who fuses at 5 degrees but suppresses at 1.5 degrees has a smaller scotoma in extent but deeper in intensity. The second subject is more likely to exhibit higher binocular imbalance than the first. Nevertheless, with the data obtained in this study this hypothesis has not been confirmed. One possible reason is the size of the stimuli used in the VR test. As explained in the discussion chapter, we would like to use a smaller stimulus to measure binocular imbalance at higher frequencies. Binocular imbalance is more evident at high frequencies and the correlation with W4D test proposed scale is more likely to happen if the stimuli is smaller.

As a result of this discussion we have added in both the results and discussion sections deeper considerations about the proposed W4D test score.

Line 308: "but not only" Consider revising the sentence structure

Revised

Line 311: "To the extend" Consider revising the sentence structure.

Revised

Lines 488 -489: Year of publication of the article missing.

Corrected

###### 

Submitted filename: Response to Reviewers_2020.07.23\_.docx

###### 

Click here for additional data file.

10.1371/journal.pone.0238047.r003

Decision Letter 1

Awadein

Ahmed

Academic Editor

© 2020 Ahmed Awadein

2020

Ahmed Awadein

This is an open access article distributed under the terms of the

Creative Commons Attribution License

, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

10 Aug 2020

Evaluation of a Virtual Reality implementation of a binocular imbalance test

PONE-D-20-15817R1

Dear Dr. Martin Gonzalez,

We're pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you'll receive an e-mail detailing the required amendments. When these have been addressed, you'll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at <http://www.editorialmanager.com/pone/>, click the \'Update My Information\' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at <authorbilling@plos.org>.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they'll be preparing press materials, please inform our press team as soon as possible \-- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact <onepress@plos.org>.

Kind regards,

Ahmed Awadein, MD, Ph.D, FRCS

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers\' comments:

10.1371/journal.pone.0238047.r004

Acceptance letter

Awadein

Ahmed

Academic Editor

© 2020 Ahmed Awadein

2020

Ahmed Awadein

This is an open access article distributed under the terms of the

Creative Commons Attribution License

, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

13 Aug 2020

PONE-D-20-15817R1

Evaluation of a Virtual Reality implementation of a binocular imbalance test

Dear Dr. Martín:

I\'m pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they\'ll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact <onepress@plos.org>.

If we can help with anything else, please email us at <plosone@plos.org>.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Ahmed Awadein

Academic Editor

PLOS ONE

[^1]: **Competing Interests:**I have read the journal\'s policy and the authors of this manuscript have the following competing interests: SM and JP promoted, with the support of the University of Oviedo, the creation of the startup VisionaryTool. Both have assisted VisionaryTool, S.L. ([www.visionarytool.com](http://www.visionarytool.com)) to create a commercial version of the VR imbalance test described in this manuscript (University of Oviedo contract FUO-EM-19-099). VisionaryTool has not had any role (writing, analysis, or control over publication) in the production of the paper. This does not alter our adherence to PLOS ONE policies on sharing data and materials.
